Atomistry » Bromine » PDB 6lue-6puu » 6p8x
Atomistry »
  Bromine »
    PDB 6lue-6puu »
      6p8x »

Bromine in PDB 6p8x: Crystal Structure of Human Kras G12C Covalently Bound to An Acryloylazetidine Acetamide Inhibitor.

Protein crystallography data

The structure of Crystal Structure of Human Kras G12C Covalently Bound to An Acryloylazetidine Acetamide Inhibitor., PDB code: 6p8x was solved by C.Mohr, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 29.86 / 2.11
Space group P 1
Cell size a, b, c (Å), α, β, γ (°) 33.327, 66.150, 78.629, 66.48, 78.75, 89.47
R / Rfree (%) 26.5 / 31.3

Other elements in 6p8x:

The structure of Crystal Structure of Human Kras G12C Covalently Bound to An Acryloylazetidine Acetamide Inhibitor. also contains other interesting chemical elements:

Calcium (Ca) 10 atoms

Bromine Binding Sites:

The binding sites of Bromine atom in the Crystal Structure of Human Kras G12C Covalently Bound to An Acryloylazetidine Acetamide Inhibitor. (pdb code 6p8x). This binding sites where shown within 5.0 Angstroms radius around Bromine atom.
In total 4 binding sites of Bromine where determined in the Crystal Structure of Human Kras G12C Covalently Bound to An Acryloylazetidine Acetamide Inhibitor., PDB code: 6p8x:
Jump to Bromine binding site number: 1; 2; 3; 4;

Bromine binding site 1 out of 4 in 6p8x

Go back to Bromine Binding Sites List in 6p8x
Bromine binding site 1 out of 4 in the Crystal Structure of Human Kras G12C Covalently Bound to An Acryloylazetidine Acetamide Inhibitor.


Mono view


Stereo pair view

A full contact list of Bromine with other atoms in the Br binding site number 1 of Crystal Structure of Human Kras G12C Covalently Bound to An Acryloylazetidine Acetamide Inhibitor. within 5.0Å range:
probe atom residue distance (Å) B Occ
A:Br305

b:41.1
occ:1.00
BR18 A:O5V305 0.0 41.1 1.0
C17 A:O5V305 1.9 41.1 1.0
C19 A:O5V305 2.9 38.7 1.0
C16 A:O5V305 2.9 39.7 1.0
CE A:MET72 3.6 34.5 1.0
CG1 A:ILE100 3.6 25.8 1.0
SD A:MET72 3.8 34.2 1.0
CB A:GLN99 4.0 26.8 1.0
CG1 A:VAL9 4.2 22.0 1.0
C20 A:O5V305 4.2 38.7 1.0
C15 A:O5V305 4.2 40.5 1.0
N A:ILE100 4.2 23.4 1.0
O A:TYR96 4.2 27.5 1.0
C A:GLN99 4.4 23.1 1.0
CD1 A:ILE100 4.5 26.1 1.0
CA A:ILE100 4.5 24.4 1.0
CD1 A:TYR96 4.6 29.9 1.0
C14 A:O5V305 4.7 39.3 1.0
CB A:ILE100 4.8 25.7 1.0
CB A:VAL9 4.8 21.9 1.0
O A:GLN99 4.8 18.9 1.0
CA A:GLN99 4.9 24.8 1.0
CE2 A:PHE78 4.9 25.5 1.0

Bromine binding site 2 out of 4 in 6p8x

Go back to Bromine Binding Sites List in 6p8x
Bromine binding site 2 out of 4 in the Crystal Structure of Human Kras G12C Covalently Bound to An Acryloylazetidine Acetamide Inhibitor.


Mono view


Stereo pair view

A full contact list of Bromine with other atoms in the Br binding site number 2 of Crystal Structure of Human Kras G12C Covalently Bound to An Acryloylazetidine Acetamide Inhibitor. within 5.0Å range:
probe atom residue distance (Å) B Occ
B:Br305

b:43.8
occ:1.00
BR18 B:O5V305 0.0 43.8 1.0
C17 B:O5V305 1.9 40.7 1.0
C16 B:O5V305 2.9 39.3 1.0
C19 B:O5V305 2.9 38.4 1.0
CG1 B:ILE100 3.6 26.4 1.0
CE B:MET72 3.8 39.6 1.0
CB B:GLN99 3.9 26.3 1.0
SD B:MET72 4.0 39.4 1.0
N B:ILE100 4.1 24.7 1.0
O B:TYR96 4.1 22.8 1.0
CG1 B:VAL9 4.2 24.7 1.0
C15 B:O5V305 4.2 40.8 1.0
C20 B:O5V305 4.2 38.9 1.0
C B:GLN99 4.3 24.7 1.0
CD1 B:ILE100 4.5 26.7 1.0
CD1 B:TYR96 4.5 20.7 1.0
CA B:ILE100 4.5 24.8 1.0
C14 B:O5V305 4.7 38.9 1.0
CB B:ILE100 4.7 25.9 1.0
CB B:VAL9 4.7 24.4 1.0
CA B:GLN99 4.8 24.9 1.0
O B:GLN99 4.8 23.5 1.0
CG2 B:VAL9 5.0 24.6 1.0
C B:TYR96 5.0 21.7 1.0

Bromine binding site 3 out of 4 in 6p8x

Go back to Bromine Binding Sites List in 6p8x
Bromine binding site 3 out of 4 in the Crystal Structure of Human Kras G12C Covalently Bound to An Acryloylazetidine Acetamide Inhibitor.


Mono view


Stereo pair view

A full contact list of Bromine with other atoms in the Br binding site number 3 of Crystal Structure of Human Kras G12C Covalently Bound to An Acryloylazetidine Acetamide Inhibitor. within 5.0Å range:
probe atom residue distance (Å) B Occ
C:Br304

b:48.3
occ:1.00
BR18 C:O5V304 0.0 48.3 1.0
C17 C:O5V304 2.0 48.4 1.0
C19 C:O5V304 2.9 44.5 1.0
C16 C:O5V304 2.9 46.2 1.0
CE C:MET72 3.1 43.1 1.0
CG1 C:ILE100 3.3 27.6 1.0
CG1 C:VAL9 4.0 20.5 1.0
CD1 C:ILE100 4.1 31.0 1.0
C20 C:O5V304 4.2 43.8 1.0
C15 C:O5V304 4.2 43.4 1.0
CE2 C:PHE78 4.3 26.1 1.0
CG C:MET72 4.3 40.2 1.0
N C:ILE100 4.4 24.9 1.0
O C:TYR96 4.5 22.0 1.0
CB C:ILE100 4.5 28.3 1.0
CA C:ILE100 4.5 26.6 1.0
SD C:MET72 4.5 40.5 1.0
CB C:GLN99 4.6 28.0 1.0
CD2 C:PHE78 4.6 24.8 1.0
CB C:MET72 4.7 38.0 1.0
C14 C:O5V304 4.8 43.4 1.0
C C:GLN99 4.8 25.8 1.0
CB C:VAL9 4.8 20.3 1.0
CG2 C:VAL9 5.0 19.8 1.0
CD1 C:TYR96 5.0 17.0 1.0

Bromine binding site 4 out of 4 in 6p8x

Go back to Bromine Binding Sites List in 6p8x
Bromine binding site 4 out of 4 in the Crystal Structure of Human Kras G12C Covalently Bound to An Acryloylazetidine Acetamide Inhibitor.


Mono view


Stereo pair view

A full contact list of Bromine with other atoms in the Br binding site number 4 of Crystal Structure of Human Kras G12C Covalently Bound to An Acryloylazetidine Acetamide Inhibitor. within 5.0Å range:
probe atom residue distance (Å) B Occ
D:Br304

b:46.8
occ:1.00
BR18 D:O5V304 0.0 46.8 1.0
C17 D:O5V304 1.9 35.7 1.0
C19 D:O5V304 2.8 35.4 1.0
C16 D:O5V304 2.9 37.6 1.0
CG1 D:ILE100 3.5 26.8 1.0
CE D:MET72 3.5 48.0 1.0
CG1 D:VAL9 3.8 25.4 1.0
CD1 D:TYR96 4.1 23.6 1.0
O D:TYR96 4.1 22.6 1.0
C20 D:O5V304 4.1 36.5 1.0
CD1 D:ILE100 4.1 25.1 1.0
C15 D:O5V304 4.2 37.2 1.0
CB D:VAL9 4.3 24.6 1.0
CG2 D:VAL9 4.5 24.0 1.0
CB D:GLN99 4.6 27.0 1.0
N D:ILE100 4.6 24.5 1.0
C14 D:O5V304 4.7 35.5 1.0
CB D:ILE100 4.8 24.9 1.0
CB D:TYR96 4.8 23.9 1.0
CA D:TYR96 4.8 23.4 1.0
CA D:ILE100 4.8 24.8 1.0
C D:TYR96 4.8 24.5 1.0
CE2 D:PHE78 4.8 31.2 1.0
CE1 D:TYR96 4.9 24.3 1.0
CG D:TYR96 4.9 22.9 1.0
CG D:MET72 5.0 44.3 1.0
CD2 D:PHE78 5.0 31.4 1.0

Reference:

Y.Shin, J.W.Jeong, R.P.Wurz, P.Achanta, T.Arvedson, M.D.Bartberger, I.D.G.Campuzano, R.Fucini, S.K.Hansen, J.Ingersoll, J.S.Iwig, J.R.Lipford, V.Ma, D.J.Kopecky, J.Mccarter, T.San Miguel, C.Mohr, S.Sabet, A.Y.Saiki, A.Sawayama, S.Sethofer, C.M.Tegley, L.P.Volak, K.Yang, B.A.Lanman, D.A.Erlanson, V.J.Cee. Discovery Ofn-(1-Acryloylazetidin-3-Yl)-2-(1H-Indol-1-Yl) Acetamides As Covalent Inhibitors of KRASG12C. Acs Med.Chem.Lett. V. 10 1302 2019.
ISSN: ISSN 1948-5875
PubMed: 31531201
DOI: 10.1021/ACSMEDCHEMLETT.9B00258
Page generated: Thu Jul 11 02:22:41 2024

Last articles

Zn in 9JPJ
Zn in 9JP7
Zn in 9JPK
Zn in 9JPL
Zn in 9GN6
Zn in 9GN7
Zn in 9GKU
Zn in 9GKW
Zn in 9GKX
Zn in 9GL0
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy